Copyright
©The Author(s) 2025.
World J Virol. Jun 25, 2025; 14(2): 103576
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.103576
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.103576
Table 4 Phases of Marburg virus with symptoms
Incubation Period (5–10 days) | ||||
Phase | Duration | Key symptoms | Outcome | Treatment |
Generalization phase | Days 1–4 | Fever (39–40 °C), headache, chills, myalgia, anorexia. Gastrointestinal symptoms like nausea, vomiting, diarrhoea | Supportive care may prevent progression | Galidesivir (BCX4430) |
Early organ phase | Days 5–13 | Hemorrhagic symptoms (petechiae, mucosal bleeding), maculopapular rash, fatigue, organ damage (kidney, liver) | Escalation in disease severity | Favipiravir (T-705), Obeldesivir |
Late organ phase/convalescence phase | Days 13+ | Recovery: Gradual resolution of symptoms. Fatality: Multiorgan failure, shock, dehydration | Recovery or death within 8–16 days | Remdesivir (GS-5734), AVI-7288 |
- Citation: Uppala PK, Karanam SK, Kandra NV, Edhi S. Marburg virus disease: Emerging threat, pathogenesis, and global public health strategies. World J Virol 2025; 14(2): 103576
- URL: https://www.wjgnet.com/2220-3249/full/v14/i2/103576.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i2.103576